Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation

Authors: Aviram M.1; Rosenblat M.; Bisgaier C.L.; Newton R.S.

Source: Atherosclerosis, Volume 138, Number 2, June 1998 , pp. 271-280(10)

Publisher: Elsevier

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Keywords: Lipid peroxidation; LDL; VLDL; HDL; Atorvastatin; Gemfibrozil; Paraoxonase

Language: English

Document Type: Research article

DOI: 10.1016/S0021-9150(98)00032-X

Affiliations: 1: The Lipid Research Laboratory, Technion Faculty of Medicine, The Rappaport Family Institute for Research in the Medical Sciences and Rambam Medical Center, Haifa 31096, Israel

This article is hosted on another website.

You may be required to register, activate a subscription or purchase the article before you can obtain the full text.

Proceed

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A